SANOFI PASTEUR, INC. (FORMERLY AVENTIS PASTEUR) for SANOFI PASTEUR INC (FORMERLY AVENTIS PASTEUR)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Patent Reform Issues Staff Director and Chief Counsel, Senate Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (95-96); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98)
Foreign entity interest: Sanofi Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP New | Staff Member, Senate Public Works Committee |
| STUART FELDMAN | Legislative Assistant Senator Hatch |
| AMY L REDL | — |
Taxation/Internal Revenue Code TAX
Legislation and other issues involving vaccine taxes and children's health, vaccine-related issues with respect to Medicaid and Medicare, and vaccine-related general tax issues. Staff Director and Chief Counsel, Senate Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (95-96); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98)
Foreign entity interest: Sanofi Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP New | Staff Member, Senate Public Works Committee |
| STUART FELDMAN | Legislative Assistant Senator Hatch |
| AMY L REDL | — |
Trade (domestic/foreign) TRD
Vaccine-related legislation, advance market commitments, and other issues. Staff Director and Chief Counsel, Senate Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (95-96); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98)
Foreign entity interest: Sanofi Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP New | Staff Member, Senate Public Works Committee |
| STUART FELDMAN | Legislative Assistant Senator Hatch |
| AMY L REDL | — |
Health Issues HCR
All vaccine and generic biological issues and related appropriation issues, including vaccines for children, pandemic concerns, influenza vaccine shortage issues, stockpile, bioterrorism, bioterrorism countermeasures, vaccine injury compensation programs, vaccine safety funding and financing, and FDA and CDC funding. Staff Director and Chief Counsel, Senate Public Works Committee, Subcommittee on Clean Air and Nuclear Safety (95-96); General Counsel, Sen. Lauch Faircloth (R-NC) (97-98)
Foreign entity interest: Sanofi Aventis Group has an interest in this legislation due to the potential impact on their U.S. business
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | See Addendum |
| MARYANNE DOLBEARE DUNLAP New | Staff Member, Senate Public Works Committee |
| STUART FELDMAN | Legislative Assistant Senator Hatch |
| AMY L REDL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.